RNA Interference, Sequencing Screen IDs Genes Mediating Tamoxifen Response

Using an RNA interference screen that relies on massively parallel sequencing, British researchers have identified new genes that seem to contribute to sensitivity or resistance to the breast cancer drug tamoxifen.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.